Il6 r expression on peripheral blood b cells of patients with multiple myeloma mm
Brown, R.; Gorenc, B.; Gibson, J.; Joshua, D.
Cytokine 3(5): 487
1991
ISSN/ISBN: 1043-4666 DOI: 10.1016/1043-4666(91)90275-i
Accession: 031798646
PDF emailed within 0-6 h: $19.90
Related References
Fang, S.; Guo, X.; Leng, X.; Li, B.; Niu, Y.; Chen, S.; Yang, L.; Li, Y. 2013: Expression down-regulation of c-Cbl and Cbl-b genes in peripheral blood mononuclear cells from multiple myeloma patients Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 29(8): 842-845Tang, J.; Chen, Q.; Zhang, F.; Zhang, W.; Duan, S.; Xiao, D. 2019: Peripheral blood exosomes from patients with multiple myeloma mediate bortezomib resistance in cultured multiple myeloma cells Nan Fang Yi Ke da Xue Xue Bao 39(4): 485-489
Zhao, L.-J.; Gao, S.; Li, X. 2018: Effects of Thalidomide on the Ratio of Th17 to Treg Cells in Peripheral Blood and Expression of IL-17 and IL-35 in Patients with Multiple Myeloma Zhongguo Shi Yan Xue Ye Xue Za Zhi 26(1): 187-191
Hou, J.; Xu, J.; Kong, X. 1998: Effects of interleukin 4 on the phenotype expression related to antibody production of peripheral blood cells in patients with multiple myeloma Chinese Medical Sciences Journal 13(2): 126-127
Vij, R.; Mazumder, A.; Klinger, M.; O'Dea, D.; Paasch, J.; Martin, T.; Weng, L.; Park, J.; Fiala, M.; Faham, M.; Wolf, J. 2014: Deep sequencing reveals myeloma cells in peripheral blood in majority of multiple myeloma patients Clinical Lymphoma Myeloma and Leukemia 14(2): 131-139.E1
Ikewaki, J.; Ogata, M.; Imamura, T.; Kohno, K.; Nakayama, T.; Kadota, J-Ichi. 2009: Development of hyperammonemic encephalopathy in patients with multiple myeloma may be associated with the appearance of peripheral blood myeloma cells Leukemia and Lymphoma 50(4): 667-669
Witzig, T.E.; Gertz, M.A.; Lust, J.A.; Kyle, R.A.; O'fallon, W.M.; Greipp, P.R. 1995: Peripheral blood myeloma cells as a prognostic factor for survival in patients with new, untreated multiple myeloma Blood 86(10 Suppl 1): 57A
Hicks, C.; Isaacs, A.; Wong, R.; Chong, B.H. 2011: CXCR4 expression on transplanted peripheral blood CD34+ cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients Annals of Hematology 90(5): 547-555
Witzig, T.E.; Gertz, M.A.; Lust, J.A.; Kyle, R.A.; Greipp, P.R. 1995: Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest? Leukemia and Lymphoma 19(5-6): 417-422
Rottenburger, C.; Kiel, K.; Bösing, T.; Cremer, F.W.; Moldenhauer, G.; Ho, A.D.; Goldschmidt, H.; Moos, M. 1999: Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation British Journal of Haematology 106(2): 545-552
Mitterer, M.; Oduncu, F.; Lanthaler, A.J.; Drexler, E.; Amaddii, G.; Fabris, P.; Emmerich, B.; Coser, P.; Straka, C. 1999: The relationship between monoclonal myeloma precursor B cells in the peripheral blood stem cell harvests and the clinical response of multiple myeloma patients British Journal of Haematology 106(3): 737-743
Paglieroni, T.; MacKenzie, M.R. 1979: In vitro cytotoxic response to human myeloma plasma cells by peripheral blood leukocytes from patients with multiple myeloma and benign monoclonal gammopathy Blood 54(1): 226-237
Callera, F.; Cavenaghi, L.; de Melo, C.áu.M.T.P. 2009: Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: a feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 40(2): 91-95
Dmoszyńska, A.; Roliński, J.; Bojarska-Junak, A.; Mańko, J.; Jawniak, D.; Walter-Croneck, A.; Soroka-Wojtaszko, M.; Hus, M. 2001: Influence of thalidomide on Bcl2 expression and proangiogenic cytokine levels in short-term culture of peripheral blood and bone marrow mononuclear cells of multiple myeloma patients Polish Journal of Pharmacology 53(6): 709-713
Luque, R.; Brieva, J.A.; Moreno, A.; Manzanal, A.; Escribano, L.; Villarrubia, J.; Velasco, J.L.; López-Jiménez, J.; Cerveró, C.; Otero, M.J.; Martínez, J.; Bellas, C.; Roldán, E. 1998: Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications Clinical and Experimental Immunology 112(3): 410-418